Exposure to triclosan augments the allergic response to ovalbumin in a mouse model of asthma

Toxicological Sciences

Volumn 132, Issue 1, 2013, Pages 96-106

  Anderson, Stacey E ^a   Franko, Jennifer ^a   Kashon, Michael L ^a   Anderson, Katie L ^a   Hubbs, Ann F ^a   Lukomska, Ewa ^a   Jean Meade, B ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Asthma; Chemical adjuvancy; Triclosan

Indexed keywords

ALLERGEN; ALUMINUM HYDROXIDE; IMMUNOGLOBULIN E; INTERLEUKIN 13; OVALBUMIN; TRICLOSAN;

ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL INFILTRATION; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; FEMALE; HEMATOLOGICAL PARAMETERS; HYPERSENSITIVITY; LUNG LAVAGE; MOUSE; NASOPHARYNGEAL ASPIRATION; NONHUMAN; PHENOTYPE; SPLEEN WEIGHT;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFECTIVE AGENTS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HYPERSENSITIVITY; INTERLEUKIN-13; LYMPH NODES; MICE; MICE, INBRED BALB C; OVALBUMIN; RNA, MESSENGER; TRICLOSAN;

ANIMALIA; MURINAE; MUS;

EID: 84876489231     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfs328     Document Type: Article

References (46)

1. Adolfsson-Erici, M., Pettersson, M., Parkkonen, J., and Sturve, J. (2002). Triclosan, a commonly used bactericide found in human milk and in the aquatic environment in Sweden. Chemosphere 46, 1485-1489.
2. Ahn, K. C., Zhao, B., Chen, J., Cherednichenko, G., Sanmarti, E., Denison, M. S., Lasley, B., Pessah, I. N., Kütz, D., Chang, D. P., et al. (2008). In vitro biologic activities of the antimicrobials triclocarban, its analogs, and triclosan in bioassay screens: Receptor-based bioassay screens. Environ. Health Perspect. 116, 1203-1210.
3. Barros, S. P., Wirojchanasak, S., Barrow, D. A., Panagakos, F. S., Devizio, W., and Offenbacher, S. (2010). Triclosan inhibition of acute and chronic inflammatory gene pathways. J. Clin. Periodontol. 37, 412-418.
4. Black, J. G., Howes, D., and Rutherford, T. (1975). Percutaneous absorption and metabolism of Irgasan DP300. Toxicology 3, 33-47.
5. Bracci, L., Vukcevic, M., Spagnoli, G., Ducreux, S., Zorzato, F., and Treves, S. (2007). Ca2+ signaling through ryanodine receptor 1 enhances maturation and activation of human dendritic cells. J. Cell. Sci. 120(Pt 13), 2232-2240.
6. Calafat, A. M., Ye, X., Wong, L. Y., Reidy, J. A., and Needham, L. L. (2008). Urinary concentrations of triclosan in the U.S. population: 2003-2004. Environ. Health Perspect. 116, 303-307.
7. Chalubinski, M., and Kowalski, M. L. (2006). Endocrine disrupters-Potential modulators of the immune system and allergic response. Allergy 61, 1326-1335.
8. Clayton, E. M., Todd, M., Dowd, J. B., and Aiello, A. E. (2011). The impact of bisphenol A and triclosan on immune parameters in the U.S. population, NHANES 2003-2006. Environ. Health Perspect. 119, 390-396.
9. DeSalva, S. J., Kong, B. M., and Lin, Y. J. (1989). Triclosan: A safety profile. Am. J. Dent. 2(Spec No), 185-196.
10. Diamanti-Kandarakis, E., Bourguignon, J. P., Giudice, L. C., Hauser, R., Prins, G. S., Soto, A. M., Zoeller, R. T., and Gore, A. C. (2009). Endocrine-disrupting chemicals: An Endocrine Society scientific statement. Endocr. Rev. 30, 293-342.
11. Eisenbarth, S. C., Piggott, D. A., Huleatt, J. W., Visintin, I., Herrick, C. A., and Bottomly, K. (2002). Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 196, 1645-1651.
12. Fairley, K. J., Purdy, R., Kearns, S., Anderson, S. E., and Meade, B. J. (2007). Exposure to the immunosuppressant, perfluorooctanoic acid, enhances the murine IgE and airway hyperreactivity response to ovalbumin. Toxicol. Sci. 97, 375-383.
13. Fang, J. L., Stingley, R. L., Beland, F. A., Harrouk, W., Lumpkins, D. L., and Howard, P. (2010). Occurrence, efficacy, metabolism, and toxicity of triclosan. J. Environ. Sci. Health. C. Environ. Carcinog. Ecotoxicol. Rev. 28, 147-171.
14. FDA. (2008). Triclosan: Supporting Information for Toxicological Evaluation by the National Toxicology Program. U.S. Food and Drug Administration, Department of Health and Human Services, Silver Spring, MD.
15. Foran, C. M., Bennett, E. R., and Benson, W. H. (2000). Developmental evaluation of a potential non-steroidal estrogen: Triclosan. Mar. Environ. Res. 50, 153-156.
16. Gee, R. H., Charles, A., Taylor, N., and Darbre, P. D. (2008). Oestrogenic and androgenic activity of triclosan in breast cancer cells. J. Appl. Toxicol. 28, 78-91.
17. Glaser, A. (2004). The ubiquitous triclosan: A common antibacterial agent exposed. Pestic You 24, 12-17. Available at: http://www.beyondpesticides.org/ pesticides/factsheets/Triclosan%20cited.pdf. Accessed November 5, 2012.
18. Gunsolley, J. C. (2006). A meta-analysis of six-month studies of antiplaque and antigingivitis agents. J. Am. Dent. Assoc. 137, 1649-1657.
19. Hubbs, A. F., Goldsmith, W. T., Kashon, M. L., Frazer, D., Mercer, R. R., Battelli, L. A., Kullman, G. J., Schwegler-Berry, D., Friend, S., and Castranova, V. (2008). Respiratory toxicologic pathology of inhaled diacetyl in sprague-dawley rats. Toxicol. Pathol. 36, 330-344.
20. Jones, R. D., Jampani, H. B., Newman, J. L., and Lee, A. S. (2000). Triclosan: A review of effectiveness and safety in health care settings. Am. J. Infect. Control 28, 184-196.
21. Kanetoshi, A., Katsura, E., Ogawa, H., Ohyama, T., Kaneshima, H., and Miura, T. (1992). Acute toxicity, percutaneous absorption and effects on hepatic mixed function oxidase activities of 2,4,4'-trichloro-2'-hydroxydiphenyl ether (Irgasan DP300) and its chlorinated derivatives. Arch. Environ. Contam. Toxicol. 23, 91-98.
22. Kligman, A. M., and Epstein, W. (1975). Updating the maximization test for identifying contact allergens. Contact Derm. 1, 231-239.
23. Kolpin, D. W., Furlong, E. T., Meyer, M. T., Thurman, E. M., Zaugg, S. D., Barber, L. B., and Buxton, H. T. (2002). Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: A national reconnaissance. Environ. Sci. Technol. 36, 1202-1211.
24. Kwak, E. S., Just, A., Whyatt, R., and Miller, R. L. (2009). Phthalates, pesticides, and bisphenol-A exposure and the development of nonoccupational asthma and allergies: How valid are the links? Open Allergy J. 2, 45-50.
25. Larsen, S. T., and Nielsen, G. D. (2007). The adjuvant effect of di-(2-ethylhexyl) phthalate is mediated through a PPARalpha-independent mechanism. Toxicol. Lett. 170, 223-228.
26. Lindströ, A., Buerge, I. J., Poiger, T., Bergqvist, P. A., Müler, M. D., and Buser, H. R. (2002). Occurrence and environmental behavior of the bactericide triclosan and its methyl derivative in surface waters and in wastewater. Environ. Sci. Technol. 36, 2322-2329.
27. Lyman, F. L., and Furia, T. (1969). Toxicology of 2, 4, 4'-trichloro-2'-hydroxydiphenyl ether. IMS. Ind. Med. Surg. 38, 64-71.
28. Marzulli, F. N., and Maiback, H. I. (1973). Antimicrobials: Experimental contact sensitization in man. J. Soc. Cosmet. Chem. 24, 399-421.
29. Melvin, T. A., and Ramanathan, M., Jr. (2012). Role of innate immunity in the pathogenesis of allergic rhinitis. Curr. Opin. Otolaryngol. Head Neck Surg. 20, 194-198.
30. Ming, X., Nichols, M., and Rothenburger, S. (2007). In vivo antibacterial efficacy of MONOCRYL plus antibacterial suture (Poliglecaprone 25 with triclosan). Surg. Infect. (Larchmt). 8, 209-214.
31. Mustafa, M., Bakhiet, M., Wondimu, B., and Modéer, T. (2000). Effect of triclosan on interferon-gamma production and major histocompatibility complex class II expression in human gingival fibroblasts. J. Clin. Periodontol. 27, 733-737.
32. Okada, H., Kuhn, C., Feillet, H., and Bach, J. F. (2010). The 'hygiene hypothesis' for autoimmune and allergic diseases: An update. Clin. Exp. Immunol. 160, 1-9.
33. Palmer, R. K., Hutchinson, L. M., Burpee, B. T., Tupper, E. J., Pelletier, J. H., Kormendy, Z., Hopke, A. R., Malay, E. T., Evans, B. L., Velez, A., et al. (2012). Antibacterial agent triclosan suppresses RBL-2H3 mast cell function. Toxicol. Appl. Pharmacol. 258, 99-108.
34. Paul, K. B., Hedge, J. M., Bansal, R., Zoeller, R. T., Peter, R., DeVito, M. J., and Crofton, K. M. (2012). Developmental triclosan exposure decreases maternal, fetal, and early neonatal thyroxine: A dynamic and kinetic evaluation of a putative mode-of-action. Toxicology 300, 31-45.
35. Rao, G. V., Tinkle, S., Weissman, D. N., Antonini, J. M., Kashon, M. L., Salmen, R., Battelli, L. A., Willard, P. A., Hoover, M. D., and Hubbs, A. F. (2003). Efficacy of a technique for exposing the mouse lung to particles aspirated from the pharynx. J. Toxicol. Environ. Health Part A 66, 1441-1452.
36. Sandborgh-Englund, G., Adolfsson-Erici, M., Odham, G., and Ekstrand, J. (2006). Pharmacokinetics of triclosan following oral ingestion in humans. J. Toxicol. Environ. Health Part A 69, 1861-1873.
37. Savage, J. H., Matsui, E. C., Wood, R. A., and Keet, C. A. (2012). Urinary levels of triclosan and parabens are associated with aeroallergen and food sensitization. J. Allergy Clin. Immunol. 130, 453-460 e457.
38. Savage, L., Rose, R., and Wilkinson, M. (2011). Airborne contact dermatitis to triclosan. Contact Derm. 65, 239-240.
39. Steinkjer, B., and Braathen, L. R. (1988). Contact dermatitis from triclosan (Irgasan DP 300). Contact Derm. 18, 243-244.
40. Stoker, T. E., Gibson, E. K., and Zorrilla, L. M. (2010). Triclosan exposure modulates estrogen-dependent responses in the female Wistar rat. Toxicol. Sci. 117, 45-53.
41. Tan, L., Nielsen, N. H., Young, D. C., and Trizna, Z. (2002). Use of antimicrobial agents in consumer products. Arch. Dermatol. 138, 1082-1086.
42. Tao, F. C., Tolloczko, B., Mitchell, C. A., Powell, W. S., and Martin, J. G. (2000). Inositol (1,4,5)trisphosphate metabolism and enhanced calcium mobilization in airway smooth muscle of hyperresponsive rats. Am. J. Respir. Cell Mol. Biol. 23, 514-520.
43. Vukcevic, M., Spagnoli, G. C., Iezzi, G., Zorzato, F., and Treves, S. (2008). Ryanodine receptor activation by Ca v 1.2 is involved in dendritic cell major histocompatibility complex class II surface expression. J. Biol. Chem. 283, 34913-34922.
44. White, S. S., Fenton, S. E., and Hines, E. P. (2011). Endocrine disrupting properties of perfluorooctanoic acid. J. Steroid Biochem. Mol. Biol. 127, 16-26.
45. Willart, M. A., and Lambrecht, B. N. (2009). The danger within: Endogenous danger signals, atopy and asthma. Clin. Exp. Allergy 39, 12-19.
46. Williams, C. M., Rahman, S., Hubeau, C., and Ma, H. L. (2012). Cytokine pathways in allergic disease. Toxicol. Pathol. 40, 205-215.